OTC Markets OTCPK - Delayed Quote USD
PeptiDream Inc. (PPTDF)
13.53
0.00
(0.00%)
At close: April 25 at 4:00:00 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in JPY | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 8 | 9 |
| Avg. Estimate | 5.17B | 14.22B | 46.15B | 46.45B |
| Low Estimate | 5.17B | 14.22B | 35B | 37.9B |
| High Estimate | 5.17B | 14.22B | 50.5B | 53.3B |
| Year Ago Sales | 4.22B | 31.91B | 46.68B | 46.15B |
| Sales Growth (year/est) | 22.37% | -55.43% | -1.13% | 0.66% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| PPTDF | -- | -- | -- | -- |
| S&P 500 | 9.62% | 4.20% | 8.36% | 13.90% |
Related Tickers
BPMUF Basilea Pharmaceutica AG
47.50
0.00%
GNMSF Genmab A/S
197.10
-1.45%
BVNKF Bavarian Nordic A/S
23.07
0.00%
INBX Inhibrx Biosciences, Inc.
12.26
+2.34%
HRMY Harmony Biosciences Holdings, Inc.
29.61
+0.61%
PTGX Protagonist Therapeutics, Inc.
44.49
-0.80%
GMAB Genmab A/S
20.59
+0.24%
RIGL Rigel Pharmaceuticals, Inc.
19.28
+1.15%
CHRS Coherus BioSciences, Inc.
1.0300
+1.98%
PCVX Vaxcyte, Inc.
32.92
-4.61%